ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Cialis (Tadalafil) steady-state blood level literature
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 103401" data-attributes="member: 3"><p>"<span style="color: #000000">Although the clinical relevance is not entirely clear, a single 20-mg dose has been shown to produce detectable electroencephalographic changes in up to 34% of healthy men.</span><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939761/#b59-dddt-4-159" target="_blank">59</a>"</p><p></p><p></p><p></p><p>Neurol Res. 2009 Apr;31(3):313-5. doi: 10.1179/174313209X382548. Epub 2008 Nov 25.</p><p></p><p><span style="font-size: 12px"><strong>EEG abnormalities during treatment with tadalafil, a phosphodiesterase type 5 inhibitor.</strong></span></p><p><span style="font-size: 12px"><strong></strong></span></p><p>Okuyucu EE1, Guven O, Duman T, Gorur S, Melek IM, Akcin S, Yilmazer S.</p><p></p><p></p><p></p><p>Abstract</p><p></p><p>OBJECTIVE:</p><p></p><p>Tadalafil is a selective phosphodiesterase type 5 (PDE-5) inhibitor approved for the treatment of erectile dysfunction. Less is known about the electroencephalography (EEG) effects of PDE-5 inhibitors, and the present study, therefore, examined the risk of EEG abnormalities associated with tadalafil.</p><p></p><p>METHOD:</p><p></p><p>EEG recordings from 35 erectile dysfunction patients taking tadalafil (20 mg) were graded for severity of EEG abnormalities (at admission, 2 and 48 hours after tadalafil administration).</p><p></p><p>RESULTS:</p><p></p><p>At admission, there were no EEG abnormalities. At second EEG, abnormalities occurred in 12 (34.3%) of the 35 patients. Eight (22.9%) patients had mild and four (11.4%) patients had moderate EEG abnormalities. At third EEG, one (2.9%) patient had mild and one (2.9%) patient had moderate EEG abnormalities.</p><p></p><p>CONCLUSION:</p><p></p><p>PDE-5 inhibitors may produce EEG abnormalities. Although the exact role of PDE in altering susceptibility to seizure remains unclear, epileptic seizures may occur during treatment with PDE inhibitors.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 103401, member: 3"] "[COLOR=#000000][FONT='inherit']Although the clinical relevance is not entirely clear, a single 20-mg dose has been shown to produce detectable electroencephalographic changes in up to 34% of healthy men.[/FONT][/COLOR][URL="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939761/#b59-dddt-4-159"]59[/URL]" Neurol Res. 2009 Apr;31(3):313-5. doi: 10.1179/174313209X382548. Epub 2008 Nov 25. [SIZE=3][B]EEG abnormalities during treatment with tadalafil, a phosphodiesterase type 5 inhibitor. [/B][/SIZE] Okuyucu EE1, Guven O, Duman T, Gorur S, Melek IM, Akcin S, Yilmazer S. Abstract OBJECTIVE: Tadalafil is a selective phosphodiesterase type 5 (PDE-5) inhibitor approved for the treatment of erectile dysfunction. Less is known about the electroencephalography (EEG) effects of PDE-5 inhibitors, and the present study, therefore, examined the risk of EEG abnormalities associated with tadalafil. METHOD: EEG recordings from 35 erectile dysfunction patients taking tadalafil (20 mg) were graded for severity of EEG abnormalities (at admission, 2 and 48 hours after tadalafil administration). RESULTS: At admission, there were no EEG abnormalities. At second EEG, abnormalities occurred in 12 (34.3%) of the 35 patients. Eight (22.9%) patients had mild and four (11.4%) patients had moderate EEG abnormalities. At third EEG, one (2.9%) patient had mild and one (2.9%) patient had moderate EEG abnormalities. CONCLUSION: PDE-5 inhibitors may produce EEG abnormalities. Although the exact role of PDE in altering susceptibility to seizure remains unclear, epileptic seizures may occur during treatment with PDE inhibitors. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Cialis (Tadalafil) steady-state blood level literature
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top